Skip to main content Help with accessibility Skip to main navigation

SODIUM ZIRCONIUM CYCLOSILICATE powder for oral suspension (Lokelma®▼) for persistent hyperkalaemia

CCG Approval Status:

Date Added: 24 - Jun - 2021
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of SODIUM ZIRCONIUM CYCLOSILICATE powder for oral suspension (Lokelma®▼) for persistent hyperkalaemia in adults following initiation by a specialist in accordance with NICE TA599.